
Join to view full profile
2 Church Street South, 3rd FloorDoctor's BuildingNew Haven, CT 06519
Dr. Gehlhausen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jeff Gehlhausen, MD, PhD, is an Assistant Professor of Dermatology and Pathology at Yale School of Medicine, Director of the Yale Autoimmune Skin Disease Clinic, and a physician-scientist focused on autoimmune and inflammatory skin disease. His research program integrates single-cell genomics, spatial transcriptomics, computational biology, and mechanistic immunology to define how tissue-intrinsic inflammatory circuits drive diseases such as cutaneous lupus erythematosus and dermatomyositis. A major focus of his laboratory is understanding how retroelements and other endogenous nucleic acid species activate innate immune sensing pathways and type I interferon programs within skin-resident cells, with the goal of identifying mechanisms that explain disease activity, treatment response, and therapeutic resistance. Clinically, Dr. Gehlhausen leads a specialized autoimmune dermatology clinic and practices dermatopathology with an emphasis on inflammatory and autoimmune dermatoses, bridging patient care, morphologic diagnosis, and molecular profiling of diseased tissue. His work is directed toward developing more precise biomarkers and therapeutic strategies for patients with autoimmune skin disease.
Education & Training
Yale-New Haven Medical CenterFellowship, Dermatopathology, 2024 - 2025
Yale-New Haven Medical CenterResidency, Dermatology, 2018 - 2021
Vanderbilt University Medical CenterInternship, Internal Medicine, 2017 - 2018
Indiana University School of MedicineClass of 2017
Certifications & Licensure
CT State Medical License 2021 - 2027
American Board of Dermatology Dermatology
American Board of Dermatology Dermatopathology
Publications & Presentations
PubMed
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review.Anshu Jonnalagadda, Rhys L Richmond, Gaurav N Pathak, Amar D Desai, Ummuguslum Yildiz-Altay
Dermatology and Therapy. 2026-08-21 - Resolution of life- and limb-threatening pyoderma gangrenosum with spesolimab.Anshu Jonnalagadda, Michael L Frisoli, Amar D Desai, Harjinder Chowdhary, William Damsky
JAAD Case Reports. 2026-08-01 - Treatment Utilization Patterns in Cutaneous Lupus Erythematosus: A Single-Center Retrospective Analysis.Aster Workineh, Julia Ross, Rachel Breidbart, Lenique Huggins, Sarika Ramachandran
Journal of the American Academy of Dermatology. 2026-07-06
Journal Articles
- A Proteasome-Resistant Fragment of NIK Mediates Oncogenic NF-κB Signaling in SchwannomasJeffrey R Gehlhausen, Charles W Yates, Steven D Rhodes, Grzegorz Nalepa, Eric Hawley, Jacquelyn D Lajiness, Human Molecular Genetics
Press Mentions
A National Medical Honor Society Honors Yale ResearchersJanuary 20th, 2026
Women’s Health Research at Yale Announces 2025 Pilot Project Program AwardsJune 10th, 2025
Dermatomyositis Cancer Screening Guidelines Get Real-World ValidationOctober 3rd, 2024
Grant Support
- Mechanisms of Retroelement-mediated Autoimmunity in Lupus ErythematosusYALE UNIVERSITY2026–2031
- Delineation of Retroelement-mediated Autoimmune Responses in Lupus ErythematosusYALE UNIVERSITY2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









